Optimization of a Fast-track Concept for Knee Joint Replacement (KneeOptOut2)

February 13, 2023 updated by: Sascha Treskatsch, Charite University, Berlin, Germany

Optimization of a Fast-track Concept for Knee Replacement: A Single-blind, Randomized, Controlled Clinical Trial

In an estimated 150,000 patients, a knee joint replacement is performed in Germany every year. The perioperative care of the patients aims at an optimal surgical technique, which leads to a high functionality in the joint, and above all at an adequate pain treatment. Patients experience pain especially intraoperatively and in the first days after the operation. The intensity of pain is a decisive factor that can hinder the patient's mobilization. In the KneeOptOut study (ethics application number EA4/009/17), which has already been successfully carried out and approved by this ethics committee, it was shown that the use of local infiltration anaesthesia (LIA) for pain therapy after primary knee endoprosthetics is comparable to catheter-supported regional anaesthesia (manuscript under review at the European Journal of Anaesthesiology). During surgery, the morphine requirement of patients in the LIA group was significantly higher than that of patients who underwent catheterization. Postoperatively, however, both subjective pain by VAS and opiate consumption were comparable.

In order to optimize the intraoperative opiate need/consumption, an early-intraoperative procedure for local infiltration anesthesia will now be compared with the previous late-intraoperative procedure. Both procedures correspond to SOP for the treatment of primary knee endoprostheses and are currently used depending on the surgeon's requirements.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 10117
        • Charité - Universitätsmedizin Berlin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

• patients undergoing elective, primary knee joint replacement in combined general anaesthesia

Exclusion Criteria:

  • heart insufficiency NYHA >2
  • liver insufficiency > CHILD B
  • evidence of diabetic polyneuropathy
  • severe adipositas BMI >40
  • patients < 18 years
  • pregnancy
  • in case of police custody
  • participation in a paralleled interventional RCT in a time frame of 30 days
  • chronic opioid therapy >3 months before scheduled surgery
  • allergy against medication required for surgery or anaesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Early-intraoperative Local infiltration technique
A distal regional anaesthesia is performed in which the nerves are blocked by a local anaesthetic in the tissue in the immediate vicinity of the operating area ("tissue infiltration technique"). The LIA is applied in a total of 4 steps during the preparation of the knee joint: 1. after the skin incision, 2. after the capsule incision, 3. after complete exposure of the knee joint, 4. when the posterior knee capsule is reached.
The local infiltration analgesia is applied in a total of 4 steps during the preparation of the knee joint: 1. after the skin incision, 2. after the capsule incision, 3. after complete exposure of the knee joint, 4. when the posterior knee capsule is reached.
Other Names:
  • early LIA
ACTIVE_COMPARATOR: Late-intraoperative Local infiltration technique
A distal regional anaesthesia is performed in which the nerves are blocked by a local anaesthetic in the tissue in the immediate vicinity of the operating area ("tissue infiltration technique"). The LIA is applied after the preparation of the femur and tibia bone shortly before the prosthesis is inserted and during the retreat from the knee joint.
Patient receive an infiltration of local anaesthetics around the knee directly after total knee replacement for postoperative pain control.
Other Names:
  • late LIA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid consumption
Time Frame: intraoperative, up to 3 hours
amount of opioids administered intraoperative measured as equivalent dose to morphin
intraoperative, up to 3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patients satisfaction (11-point likert scale)
Time Frame: up to 7 days postoperatively
global satisfaction of patients
up to 7 days postoperatively
time to first mobilisation (walking)
Time Frame: up to 7 days postoperatively
time from end of surgery until patients is able to walk
up to 7 days postoperatively
time to achieve full joint mobility
Time Frame: up to 7 days postoperatively
time to achieve full joint mobility (0/0/90°)
up to 7 days postoperatively
rescue pain medication
Time Frame: up to 7 days postoperatively
number of patients requiring rescue pain medication
up to 7 days postoperatively
time to discharge
Time Frame: up to 14 days postoperatively
time to discharge from hospital
up to 14 days postoperatively
time to first mobilisation (standing)
Time Frame: up to 48 hours postoperatively
time from end of surgery until patients is able to stand
up to 48 hours postoperatively
Janda grade of both legs at first day after surgery
Time Frame: up to 24h postoperatively
best Janda grade in both legs the day after surgery
up to 24h postoperatively
Pain intensity
Time Frame: up to 7 days postoperatively
intensity of pain in all patients meausered by numeric rating scale (NRS)
up to 7 days postoperatively
Opioid consumption (hospital)
Time Frame: up to 14 days postoperatively
amount of opioids administered until discharge measured as equivalent dose to morphin
up to 14 days postoperatively
delirium
Time Frame: up to 7 days postoperatively
incidence of postoperative delirium measured by Nursing Delirium Screening Scale (NuDeSc)
up to 7 days postoperatively
postoperative nausea and vomiting (PONV)
Time Frame: up to 7 days postoperatively
incidence of PONV
up to 7 days postoperatively
surgeon satisfaction (6-point likert scale)
Time Frame: intraoperative, up to 3 hours
satisfaction of surgeon in points of clarity of the operative field, change of the operative field by LIA and overall satisfaction represented in one value
intraoperative, up to 3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2019

Primary Completion (ACTUAL)

February 28, 2021

Study Completion (ACTUAL)

July 30, 2021

Study Registration Dates

First Submitted

April 16, 2019

First Submitted That Met QC Criteria

April 16, 2019

First Posted (ACTUAL)

April 19, 2019

Study Record Updates

Last Update Posted (ESTIMATE)

February 14, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KneeOptOut2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe